Mandaluyong allocates P200 million for COVID-19 vaccines | Inquirer News

Mandaluyong allocates P200 million for COVID-19 vaccines

By: - Reporter / @DYGalvezINQ
/ 08:31 PM January 05, 2021
Mandaluyong City

Photo from Mandaluyong City Public Information Office.

MANILA, Philippines — Mandaluyong City has allotted P200 million for the purchase of COVID-19 vaccines for its residents.

The Mandaluyong Public Information Office said Mayor Menchie Abalos formed a committee that will oversee the purchase of the vaccines.


She also directed the committee to ensure that vaccine distribution will be effective.

“Pipilitin namin, sa abot ng aming makakaya at sa pakikipagtulungan ng bawat isa, na mabakunahan ang bawat Mandaleño,” Mayor Abalos said in a statement.


(We will try, to the best of our abilities, to vaccinate each Mandaleño.)

Bagong taon, bagong pag-asa, bagong kinabukasan.

Ang Lungsod ng Mandaluyong ay naglaan na ng P200M budget para sa…

Posted by Mandaluyong City Public Information Office on Monday, January 4, 2021

Mandaluyong City’s announcement came after several local government units such as Makati City and Manila City announced efforts to set aside funds and register residents who would receive a COVID-19 vaccine once it arrives in the country.

Pasig City Mayor Vico Sotto has also stated that around P300 million from the city’s 2021 budget has been allotted for the procurement and purchase of COVID-19 vaccines.

Meanwhile, the city council of Quezon City has given the local government the green light to purchase vaccines against COVID-19 for its constituents.

The city has allocated an initial P1 billion in its 2021 budget to purchase vaccines and supplies needed for the inoculation.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19 Vaccines, Mandaluyong City, P200 million
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.